 |
|
|
|
|
|
|
|
 |
|
||||||
 |
 |
 |
 |
 |
 |
 |
|
Analyst Conference Call Notes by William Meyers
Celsion
CLSN
conference date: May 14, 2021 @ 7:00 AM Pacific Time
Celsion: Big Gains Possible in July [May 19, 2020]
Celsion Interim Thermodox Analysis Recommends Continuation of Study [November 4, 2019]
Celsion Approaches Drug Trial Binary [May 19, 2019]
Independent NIH Analysis of Thermodox plus RFA for Liver Cancer [September 12, 2016]
RFA plus lyso-thermosensitive liposomal doxorubicin [June 10, 2016] all the details on Thermodox studies
| 2021 | |||
| Celsion Q1 2021 call notes |
|||
| May 14, 2021 | |||
| 2020 | |||
| Celsion Q1 2020 call notes |
Celsion Q2 2020 call notes |
Celsion Q3 2020 call notes |
Celsion Q4 2020 call notes |
| May 15, 2020 | Aug. 14, 2020 | Nov. 16, 2020 | Mar. 19, 2021 |
| 2019 | |||
| Celsion Q1 2019 call notes |
Celsion Q2 2019 call notes |
Celsion Q3 2019 call notes |
Celsion Q4 2019 call notes |
| May 15, 2019 | Aug. 15, 2019 | Nov. 15, 2019 | March 26, 2020 |
2018 |
|||
| Celsion Q4 2018 call notes |
|||
May 10, 2018 |
Aug. 14, 2018 |
Nov. 15, 2018 |
Mar. 29, 2019 |
2017 |
|||
May 12, 2017 |
August 15, 2017 |
Nov. 14, 2017 |
March 27, 2018 |
2016 |
|||
08/15/2016 |
11/10/2016 |
03/16/2017 |
|
Celsion (CLSN) is a clinical-stage biotechnology company specializing in cancer therapies. Its lead product is ThermoDox for liver cancer.
Celsion web site
More Analyst Conference Pages:
| AGEN |
| AGIO |
| ALNY |
| ALXN |
| AMAT |
| AMGN |
| APRE |
| BIIB |
| BMY |
| CLDX |
| DRNA |
| EPZM |
| GILD |
| GLYC |
| ILMN |
| INCY |
| INO |
| IONS |
| ISRG |
| MCHP |
| MRNA |
| PLX |
| REGN |
| RNA |
| SAGE |
| SGEN |
| VBLT |
| VSTM |
| XLRN |
Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.
Copyright 2021 William P. Meyers